# Auren Rx reviews (2026): GLP-1 telehealth sellers | This GLP Tirzepatide costs $80 a month more than semaglutide, and both commitment rates are published. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/auren-rx Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Two rates per molecule, both published # Auren Rx review Tirzepatide costs $80 a month more than semaglutide, and both commitment rates are published. ## The verdict Auren Rx publishes $149 a month for semaglutide and $229 for tirzepatide on a subscription. The rate without one is $30 higher on each. Coverage is 50 states. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection States 50 From From $149/mo Prescription Required Compounded Yes — not FDA-approved Availability 50 states Auren Rx sells both molecules by weekly injection. Each carries two rates, one subscribed and one not. A separate microdose track is priced lower. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping. The pages state rates rather than describe care. No clinician is named. The subscription can be paused or canceled at any time. Publishing the no-commitment rate beside it removes the usual guesswork. 2. ## What happens when the dose goes up? Nothing published says what either figure does at a higher dose. That is the gap in an otherwise plain page. 3. ## What the price includes Six months of semaglutide is $894 subscribed or $1,074 without. Tirzepatide is $1,374 subscribed or $1,554 without. The $30 gap is the cost of declining the subscription. 4. ## What it claims, and what it cites Both lines are compounded. A pharmacy prepares them to order. The FDA does not review a compounded preparation before dispensing. ## Where it holds up, and where it does not - Strength: Both commitment rates published - Strength: The subscription cancels at any time - Strength: The gap between them is $30 - Strength: Coverage in 50 states - Limitation: Tirzepatide costs $80 a month more - Limitation: Dose behavior is not published - Limitation: No milligram appears beside a figure - Limitation: The pharmacy is not identified ## What the evidence says about this kind of treatment The assessment above is about Auren Rx. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who wants a subscription that cancels at any time, with the no-commitment rate in view. Wrong for A reader who needs to know what happens to $149 at a higher dose. ## The evidence behind what Auren Rx prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Auren Rx compares | Seller | Who it suits | Go | | --- | --- | --- | | Aspen | Readers who want the escalation question closed and need no separate molecule price | | | Somi Health | Readers who want the dose question answered in writing before anything else | | | Silhouette MD | Readers who want an unqualified number and will pay the tablet premium for one | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Jently](https://thisglp.com/reviews/jently) [Joey Med](https://thisglp.com/reviews/joey-med) [Joi + Blokes](https://thisglp.com/reviews/joi-and-blokes) [JRNYS](https://thisglp.com/reviews/jrnys) [JumpstartMD](https://thisglp.com/reviews/jumpstartmd) [June Health](https://thisglp.com/reviews/june-health) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Does tirzepatide cost more? Yes. It is $229 subscribed against $149 for semaglutide, an $80 step. What does declining the subscription cost? $30 a month on either molecule, or $180 over six. Which states are served? Fifty. Is Auren Rx legit? Auren Rx is a GLP-1 telehealth sellers service. Its stated availability: 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is Auren Rx expensive compared with other GLP-1 telehealth sellers? Auren Rx publishes a starting figure of $149/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Auren Rx below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).